disease remission

April 24, 2017

Cannabinoid Combo Therapy Ended Teen’s Bowel Disease Symptoms, Study Reports

News

A 13-year-old boy whose Crohn’s disease and colitis had failed to respond to standard treatments became symptom-free with a combo therapy that included cannabinoids, the cannabinoid therapy maker Vitality Biopharma reported. The study ... Read more

January 18, 2017

Cellceutix Enrolls Second Group in Phase 2 Trial of IBD Therapy Brilacidin

News

Cellceutix has completed enrolling a second cohort of patients with mild-to-moderate ulcerative proctitis/ulcerative proctosigmoiditis (UP/UPS), two forms of inflammatory bowel disease (IBD), in its Phase 2 clinical trial evaluating brilacidin (PMX-30063). ... Read more

June 7, 2016June 7, 2016

Some Crohn’s Disease Patients Reach Remission with Risankizumab

Crohn's Disease, IBD News, News

Phase 2 clinical trial results showed that patients with moderate to severe active Crohn’s disease can achieve disease remission when treated with risankizumab, a Boehringer Ingelheim investigational biologic product. The study, “IL-23 ... Read more

September 17, 2015September 17, 2015

Type I IFNs Incapable of Inducing Remission in Ulcerative Colitis

News

In a recent review study entitled “Type I interferons for induction of remission in ulcerative colitis”, the authors revised clinical studies and concluded that type I interferon therapy, successfully used in ... Read more